The effect for oncology of the national coverage determination for erythropoiesis-stimulating agents.
Jorgenson
James A
JA
University of Utah Health Science Center, Salt Lake City, USA.
D014487:Centers for Medicare and Medicaid Services, U.S.; D006397:Hematinics / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D019458:Insurance Coverage; D007348:Insurance, Health; D008495:Medical Oncology; D014481:United States
D006397:Hematinics